These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11241900)

  • 21. Role of DNA flow cytometry and immunocytochemical analysis in diagnosis of malignant effusions.
    Kundu R; Handa U; Mohan H
    Diagn Cytopathol; 2012 Oct; 40(10):887-92. PubMed ID: 21485027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic implications of telomerase activity in pleural effusions.
    Dikmen G; Dikmen E; Kara M; Sahin E; Doğan P; Ozdemir N
    Eur Respir J; 2003 Sep; 22(3):422-6. PubMed ID: 14516130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
    Gupta S; Sodhani P; Jain S
    J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions.
    Davidson B; Stavnes HT; Hellesylt E; Hager T; Zeppa P; Pinamonti M; Wohlschlaeger J
    Hum Pathol; 2016 Jan; 47(1):104-8. PubMed ID: 26520416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.
    Duggan BD; Wan M; Yu MC; Roman LD; Muderspach LI; Delgadillo E; Li WZ; Martin SE; Dubeau L
    J Natl Cancer Inst; 1998 Feb; 90(3):238-42. PubMed ID: 9462682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R; Aftab K; Hasan SH; Pervez S
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytological evaluation and significance of cell cannibalism in effusions and urine cytology.
    Ahmed Wani F; Bhardwaj S
    Malays J Pathol; 2015 Dec; 37(3):265-70. PubMed ID: 26712673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions.
    Zendehrokh N; Rehnberg J; Dejmek A
    Acta Cytol; 2007; 51(6):886-92. PubMed ID: 18077981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of human telomerase reverse transcriptase mRNA in malignant pleural effusions: A preliminary report for in situ hybridization detection.
    Shu J; Sun GY; Liu AP; Liu J
    Clin Chim Acta; 2007 Jun; 381(2):131-5. PubMed ID: 17399696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of the telomerase assay in peritoneal washing fluids.
    Tseng CJ; Jain S; Hou HC; Liu W; Pao CC; Lin CT; Horng SG; Soong YK; Hsueh S
    Gynecol Oncol; 2001 Jun; 81(3):420-3. PubMed ID: 11371132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of toluidine blue-stained wet films in effusion cytology.
    Erkiliç S; Koçer NE
    Acta Cytol; 2006; 50(4):407-9. PubMed ID: 16901004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ telomerase activity in pleural effusions: a promising marker for malignancy.
    Dejmek A; Yahata N; Ohyashiki K; Ebihara Y; Kakihana M; Hirano T; Kawate N; Kato H
    Diagn Cytopathol; 2001 Jan; 24(1):11-5. PubMed ID: 11135462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
    Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
    Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy and added value of triage beyond segregating potentially neoplastic effusions in immediate wet preparation.
    Arabi H; Yousef N; Han L; Bandyopadhyay S; Feng J; Al-Abbadi M
    Acta Cytol; 2009; 53(1):71-6. PubMed ID: 19248556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential diagnostic value of B72.3, Ber-EP4 and calretinin in serous effusions].
    Li XJ; Pan QJ; Shen GH; Liu XY; Sun YT
    Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):438-41. PubMed ID: 16188134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.